Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes

ClinicalTrials.gov ID: NCT02034513

Public ClinicalTrials.gov record NCT02034513. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes (SWITCH 1)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to compare the safety and efficacy of insulin degludec (IDeg) and insulin glargine (IGlar), both with insulin aspart (IAsp) as mealtime insulin in subjects with type 1 diabetes.

Study identification

NCT ID
NCT02034513
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
501 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2014 (Actual)
Primary completion
Jan 11, 2016 (Actual)
Completion
Jan 11, 2016 (Actual)
Last update posted
Jan 2, 2019

2014 – 2016

United States locations

U.S. sites
92
U.S. states
30
U.S. cities
84
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35215-7502 —
Novo Nordisk Investigational Site Goodyear Arizona 85395 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site Long Beach California 90807 —
Novo Nordisk Investigational Site Rancho Cucamonga California 91730-3063 —
Novo Nordisk Investigational Site San Mateo California 94401 —
Novo Nordisk Investigational Site San Ramon California 94583 —
Novo Nordisk Investigational Site Santa Monica California 90404 —
Novo Nordisk Investigational Site Upland California 91786 —
Novo Nordisk Investigational Site Ventura California 93003 —
Novo Nordisk Investigational Site Denver Colorado 80220 —
Novo Nordisk Investigational Site Cooper City Florida 33024 —
Novo Nordisk Investigational Site Fleming Island Florida 32003 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33312 —
Novo Nordisk Investigational Site Hialeah Florida 33012 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Jacksonville Florida 32207 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Jacksonville Florida 32256 —
Novo Nordisk Investigational Site Miami Florida 33130 —
Novo Nordisk Investigational Site Miami Florida 33156 —
Novo Nordisk Investigational Site Miami Florida 33175 —
Novo Nordisk Investigational Site Miami Springs Florida 33166 —
Novo Nordisk Investigational Site New Port Richey Florida 34652 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33026 —
Novo Nordisk Investigational Site Port Charlotte Florida 33952 —
Novo Nordisk Investigational Site Port Orange Florida 32127 —
Novo Nordisk Investigational Site Lawrenceville Georgia 30046 —
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596 —
Novo Nordisk Investigational Site Arlington Heights Illinois 60005-4144 —
Novo Nordisk Investigational Site Chicago Illinois 60611 —
Novo Nordisk Investigational Site Crystal Lake Illinois 60012 —
Novo Nordisk Investigational Site Skokie Illinois 60077 —
Novo Nordisk Investigational Site Anderson Indiana 46011 —
Novo Nordisk Investigational Site Indianapolis Indiana 46234 —
Novo Nordisk Investigational Site Council Bluffs Iowa 51501 —
Novo Nordisk Investigational Site West Des Moines Iowa 50265 —
Novo Nordisk Investigational Site Lenexa Kansas 66219 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Livonia Michigan 48152 —
Novo Nordisk Investigational Site Hazelwood Missouri 63042 —
Novo Nordisk Investigational Site Jefferson City Missouri 65109 —
Novo Nordisk Investigational Site Kansas City Missouri 64106 —
Novo Nordisk Investigational Site Billings Montana 59101 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Henderson Nevada 89052-2649 —
Novo Nordisk Investigational Site Las Vegas Nevada 89148 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site Hamilton New Jersey 08690 —
Novo Nordisk Investigational Site Albany New York 12206 —
Novo Nordisk Investigational Site Harrison New York 10528 —
Novo Nordisk Investigational Site Mineola New York 11501 —
Novo Nordisk Investigational Site Syracuse New York 13210 —
Novo Nordisk Investigational Site Asheville North Carolina 28803 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site Morehead City North Carolina 28557 —
Novo Nordisk Investigational Site Raleigh North Carolina 27609 —
Novo Nordisk Investigational Site Toledo Ohio 43614 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104 —
Novo Nordisk Investigational Site Jenkintown Pennsylvania 19046 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224-2215 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Amarillo Texas 79106 —
Novo Nordisk Investigational Site Austin Texas 78731 —
Novo Nordisk Investigational Site Austin Texas 78758 —
Novo Nordisk Investigational Site Carrollton Texas 75007 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site El Paso Texas 79912 —
Novo Nordisk Investigational Site Houston Texas 77024 —
Novo Nordisk Investigational Site Houston Texas 77079 —
Novo Nordisk Investigational Site Katy Texas 77450 —
Novo Nordisk Investigational Site Mesquite Texas 75149 —
Novo Nordisk Investigational Site Richardson Texas 75080 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site Schertz Texas 78154 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Salt Lake City Utah 84102 —
Novo Nordisk Investigational Site Salt Lake City Utah 84107 —
Novo Nordisk Investigational Site Chesapeake Virginia 23321 —
Novo Nordisk Investigational Site Norfolk Virginia 23510 —
Novo Nordisk Investigational Site Federal Way Washington 98003 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Richland Washington 99352 —
Novo Nordisk Investigational Site Spokane Washington 99208 —
Novo Nordisk Investigational Site Walla Walla Washington 99362-4445 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02034513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2019 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02034513 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →